In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.25 million on Nov 15 ’24. In the deal valued at $27.73 per share,9,061 shares were sold. As a result of this transaction, Yale Catriona now holds 74,158 shares worth roughly $2.37 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Yale Catriona sold 10,000 shares, generating $351,890 in total proceeds. Upon selling the shares at $35.19, the Chief Development Officer now owns 74,158 shares.
Before that, CATRIONA YALE bought 10,000 shares. Akero Therapeutics Inc shares valued at $327,400 were divested by the Officer at a price of $32.74 per share.
Citigroup initiated its Akero Therapeutics Inc [AKRO] rating to a Buy in a research note published on November 18, 2024; the price target was $65. Cantor Fitzgerald began covering AKRO with “an Overweight” recommendation on September 19, 2023. UBS started covering the stock on August 28, 2023. It rated AKRO as “a Buy”.
Price Performance Review of AKRO
On Monday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock fall -0.28% to $32.01. Over the last five days, the stock has lost -2.20%. Akero Therapeutics Inc shares have risen nearly 37.09% since the year began. Nevertheless, the stocks have risen 91.22% over the past one year. While a 52-week high of $37.00 was reached on 03/04/24, a 52-week low of $15.32 was recorded on 02/06/24. SMA at 50 days reached $30.41, while 200 days put it at $25.68.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 31.54, which if violated will result in even more drops to 31.08. On the upside, there is a resistance level at 32.52. A further resistance level may holdings at 33.04. The Relative Strength Index (RSI) on the 14-day chart is 53.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.98, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.78%. Stochastics %K at 64.13% indicates the stock is a holding.
How much short interest is there in Akero Therapeutics Inc?
A steep rise in short interest was recorded in Akero Therapeutics Inc stocks on 2024-11-15, dropping by -1.09 million shares to a total of 3.62 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 4.72 million shares. There was a decline of -30.09%, which implies that there is a negative sentiment for the stock.
